Company-wide revenue
Reported revenue in 2021 ¥78.62B Reported revenue in 2025 ¥87.63B
- growth amount
- +¥9.01B
- growth annualized
- +2.8%
- growth total
- +11.5%
Japanese company profile · 2533
Oenon Holdings, Inc.
In its FY2025 public filing, Oenon Holdings, Inc. reports Alcoholic Beverages, Enzyme Pharmaceuticals, Real Estate. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: オエノンホールディングス株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
Oenon Holdings, Inc.'s largest reported business by revenue in FY2025 was Alcoholic Beverages.
The business with the highest reported segment profit in FY2025 was Alcoholic Beverages.
FY2025 · fiscal year ended December 2025 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Alcoholic Beverages | ¥81.58B ↗ | 93.1% | ¥2.56B ↗ |
| Enzyme Pharmaceuticals | ¥4.64B ↗ | 5.3% | ¥807M ↗ |
| Real Estate | ¥1.32B ↗ | 1.5% | ¥763M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended December 2025. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Alcoholic Beverages
- 酒類
- Enzyme Pharmaceuticals
- 酵素医薬品
- Real Estate
- 不動産
- Processed Starch
- 加工用澱粉
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Alcoholic Beverages
- 酒類
- Enzyme Pharmaceuticals
- 酵素医薬品
- Real Estate
- 不動産
- Processed Starch
- 加工用澱粉
- Sales
- 売上高
- Operating profit
- 営業利益
Reported Sales by business over time
Reported Sales by business over time
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Alcoholic Beverages | ¥71.11B | ¥72.91B | ¥78.81B | ¥78.73B | ¥81.58B |
| Enzyme Pharmaceuticals | ¥3.28B | ¥3.4B | ¥3.49B | ¥4.16B | ¥4.64B |
| Real Estate | ¥360M | ¥460M | ¥1.23B | ¥1.14B | ¥1.32B |
| Processed Starch | ¥3.81B | ¥4.28B | ¥1.34B | — | — |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
Alcoholic Beverages
Reported revenue in 2021 ¥71.11B Reported revenue in 2025 ¥81.58B
- growth amount
- +¥10.47B
- growth total
- +14.7%
View original filing
Real Estate
Reported revenue in 2021 ¥360M Reported revenue in 2025 ¥1.32B
- growth annualized
- +38.4%
- growth total
- +267.2%
View original filing
Enzyme Pharmaceuticals
Reported revenue in 2021 ¥3.28B Reported revenue in 2025 ¥4.64B
- growth amount
- +¥1.37B
- growth annualized
- +9.1%
- growth total
- +41.7%
View original filing
Real Estate
Reported profit margin in 2022 +46.5%
Reported profit margin in 2025 +57.7%
- growth margin points
- +11.2
View original filing
Enzyme Pharmaceuticals
Reported profit margin in 2022 +10.9%
Reported profit margin in 2025 +17.4%
- growth margin points
- +6.5
View original filing
Alcoholic Beverages
Reported profit margin in 2022 -1.3%
Reported profit margin in 2025 +3.1%
- growth margin points
- +4.4
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended December 2025
The source document may be in Japanese.
Filing ID: S100XRFQ
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.